Your browser doesn't support javascript.
loading
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.
Hua, Camille; Boussemart, Lise; Mateus, Christine; Routier, Emilie; Boutros, Céline; Cazenave, Hugo; Viollet, Roxane; Thomas, Marina; Roy, Séverine; Benannoune, Naima; Tomasic, Gorana; Soria, Jean-Charles; Champiat, Stéphane; Texier, Matthieu; Lanoy, Emilie; Robert, Caroline.
Afiliação
  • Hua C; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Boussemart L; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Mateus C; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Routier E; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Boutros C; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Cazenave H; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Viollet R; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Thomas M; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Roy S; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Benannoune N; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Tomasic G; Department of Pathology, Cancer Campus, Gustave Roussy Institute, Villejuif, France.
  • Soria JC; Department of Early Clinical Development, Cancer Campus, Gustave Roussy Institute, Villejuif, France4Paris-Sud University, Grand Paris, France.
  • Champiat S; Department of Early Clinical Development, Cancer Campus, Gustave Roussy Institute, Villejuif, France5Institut National de la Santé et de la Recherche Médicale U 981, Cancer Campus, Gustave Roussy Institute, Grand Paris, France.
  • Texier M; Biostatistics and Epidemiology Unit, Gustave-Roussy Institute, Villejuif, France7Centre de recherche en épidémiologie et Santé des populations, Institut National de la Santé et de la recherche médicale, Université Paris-Sud, Université de Versailles Saint.
  • Lanoy E; Biostatistics and Epidemiology Unit, Gustave-Roussy Institute, Villejuif, France7Centre de recherche en épidémiologie et Santé des populations, Institut National de la Santé et de la recherche médicale, Université Paris-Sud, Université de Versailles Saint.
  • Robert C; Department of Dermatology, Cancer Campus, Gustave Roussy Institute, Villejuif, France5Institut National de la Santé et de la Recherche Médicale U 981, Cancer Campus, Gustave Roussy Institute, Grand Paris, France.
JAMA Dermatol ; 152(1): 45-51, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26501224
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Vitiligo / Anticorpos Monoclonais Humanizados / Melanoma / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Vitiligo / Anticorpos Monoclonais Humanizados / Melanoma / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França